AJR Am J Roentgenol

1. BALBI M, Ledda RE, Milanese G, Ruggirello M, et al
   Characteristics and Outcomes of Lung-RADS Version 2022 Atypical Pulmonary Cysts With Ground-Glass Components on Lung Cancer Screening CT: Secondary Analysis of BioMILD Trial Data.
   AJR Am J Roentgenol. 2025 Aug 6. doi: 10.2214/AJR.25.33427.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. CHENG JJ, Dai ZY, Wang FQ, Zhang HL, et al
   ASO Author Reflections: Leveraging Individual Patient Data to Refining Surgical Decision Making in Spread Through Air Spaces: Positive Stage I Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17995.
   

   >> Share

   
   
3. SUN J, Shen Z, Han L, Wan S, et al
   The Prognostic Significance of SMARCA4 Deficiency in Early-Stage Pulmonary Large Cell Carcinoma.
   Ann Surg Oncol. 2025;32:7049-7058.
   

   >> Share

   
   

   
   Anticancer Res

4. KOH JW, Park SJ
   Down-regulation of SMPDL3B Inhibits the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells.
   Anticancer Res. 2025;45:3275-3286.
   

   >> Share

   
   
5. RADES D, Doehring L, Delikanli C, Groh EM, et al
   Estimating the Risk of Radiation Pneumonitis in Elderly Patients With Lung Cancer.
   Anticancer Res. 2025;45:3347-3353.
   

   >> Share

   
   

   
   BMC Cancer

6. PENG Z, Wang Y, Qi Y, Hu H, et al
   Application of prediction model based on CT radiomics in prognosis of patients with non-small cell lung cancer.
   BMC Cancer. 2025;25:1273.
   

   >> Share

   
   

   
   Cancer

7. NIERENGARTEN MB
   Effective and efficient large-scale lung cancer screening: Low-dose computed tomography screening for lung cancer enables early diagnosis in asymptomatic, high-risk individuals and has been shown to reduce lung cancer-related mortality.
   Cancer. 2025;131:e35956.
   

   >> Share

   
   

   
   Cancer Lett

8. MA G, Wang D, Deng Y, Huang W, et al
   Targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition to delay emergence of acquired resistance of lung cancer to osimertinib.
   Cancer Lett. 2025;632:217962.
   

   >> Share

   
   

   
   Cancer Sci

9. WEI T, Cheng Y, Ge J, Zhu M, et al
   The Pro-Apoptotic Effect of Glucose Restriction in NSCLC via AMPK-Regulated Circadian Clock Gene Bmal1.
   Cancer Sci. 2025;116:2101-2112.
   

   >> Share

   
   
10. KIJIMA T, Kato T, Goto Y, Kuribayashi K, et al
    KEYNOTE-A17: First-Line Pembrolizumab Plus Cisplatin-Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma.
    Cancer Sci. 2025;116:2208-2217.
    

    >> Share

    
    
11. YOKOYAMA T, Saitoh M, Miyazawa K
    TGF-beta Enhances Doxorubicin Resistance and Anchorage-Independent Growth in Cancer Cells by Inducing ALDH1A1 Expression.
    Cancer Sci. 2025;116:2176-2188.
    

    >> Share

    
    
12. MO X, He J, Shen X, Li C, et al
    Connexin43 Promotes the Invasion and Metastasis of Lung Squamous Cell Carcinoma via GJIC-Dependent Ca(2+)/ERK Signaling Activation.
    Cancer Sci. 2025;116:2086-2100.
    

    >> Share

    
    

    
    Clin Exp Metastasis

13. CHENG L, Li S, Cui Z, Sun X, et al
    G-protein coupled receptor 183 (GPR183) inhibits visceral metastasis of non-small cell lung cancer.
    Clin Exp Metastasis. 2025;42:44.
    

    >> Share

    
    

    
    Clin Lung Cancer

14. BLOCH Z, Jensen S, Sorensen V, Langer SW, et al
    The Effect of Exercise on Quality of Life in Patients With Advanced Lung Cancer: A Secondary Analysis of a Randomized Controlled Trial.
    Clin Lung Cancer. 2025 Jul 9:S1525-7304(25)00149.
    

    >> Share

    
    
15. KALKHORAN HA, Verschueren MV, Peters BJM, van de Garde EMW, et al
    Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?
    Clin Lung Cancer. 2025 Jul 17:S1525-7304(25)00154.
    

    >> Share

    
    

    
    Int J Cancer

16. LI W, Pan S, Qian J, Xia Y, et al
    Comparisons of blood, upper respiratory tract and gut viromes from patients with lung cancer and healthy persons.
    Int J Cancer. 2025 Aug 8. doi: 10.1002/ijc.70075.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

17. MONTI S, Giuseppe P, Caroprese M, Cella L, et al
    External Validation of Dose Patterns and Dosimetric Predictors for Radiation-Induced Esophagitis in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06043.
    

    >> Share

    
    

    
    J Clin Invest

18. XIONG T, Wang G, Yu P, Li Z, et al
    CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors.
    J Clin Invest. 2025;135:e189920.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

19. PARIKH MJ, Russo MG, Tompkins AK, Erkmen CP, et al
    Reply: Multilevel bridge to lung cancer screening adherence.
    J Thorac Cardiovasc Surg. 2025 Aug 7:S0022-5223(25)00559.
    

    >> Share

    
    

    
    J Thorac Oncol

20. ZHANG B, Shah KB, Parma M, Wang K, et al
    Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case Report.
    J Thorac Oncol. 2025;20:1131-1138.
    

    >> Share

    
    
21. NAKAZAWA S, Pecci F, Ricciuti B, Gottlieb FH, et al
    Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC.
    J Thorac Oncol. 2025;20:1035-1049.
    

    >> Share

    
    
22. JANNE PA, Goto Y, Kubo T, Ninomiya K, et al
    Final analysis results and patient-reported outcomes from DESTINY-Lung02-a dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic non-small cell lung cancer.
    J Thorac Oncol. 2025 Jul 30:S1556-0864(25)00981.
    

    >> Share

    
    
23. BANERJEE A, Vathiotis I, Halder D, Sen U, et al
    Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity.
    J Thorac Oncol. 2025 Aug 2:S1556-0864(25)00773.
    

    >> Share

    
    
24. HERBST RS, Prizant H, Ruderman D, Conway J, et al
    Digital Versus Manual PD-L1 Scoring in Advanced Non-Small Cell Lung Cancer From the IMpower110 and IMpower150 Trials.
    J Thorac Oncol. 2025 Aug 2:S1556-0864(25)00983.
    

    >> Share

    
    
25. AL-RABI K, El Khatib O, Abdeljalil R, Talab Y, et al
    Lung Cancer in Jordan.
    J Thorac Oncol. 2025;20:1007-1017.
    

    >> Share

    
    

    
    Lung Cancer

26. ZENG L, Tong F, Xu X, Song L, et al
    Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer.
    Lung Cancer. 2025;207:108684.
    

    >> Share

    
    
27. LIU G, Liu Y, Jing H, Chen T, et al
    Global, regional, and national economic consequences of tracheal, bronchial, and lung cancer.
    Lung Cancer. 2025;207:108685.
    

    >> Share

    
    
28. ZHANG Y, Zhao J, Ma Z, Yi J, et al
    Immune checkpoint inhibitors for advanced non-small cell lung cancer with preexisting COPD and CT-defined emphysema: A systematic review and meta-analysis.
    Lung Cancer. 2025;207:108700.
    

    >> Share

    
    
29. GRONBERG M, Aanerud M, Halvorsen TO, Killingberg KT, et al
    Associations between progastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) and survival in patients with limited-stage small cell lung cancer (LS SCLC) receiving chemoradiotherapy (CRT).
    Lung Cancer. 2025;207:108678.
    

    >> Share

    
    
30. DINGEMANS AC, Syrigos K, Livi L, Paulus A, et al
    Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial.
    Lung Cancer. 2025;207:108683.
    

    >> Share

    
    

    
    Oncogene

31. SHI R, Farnsworth DA, Febres-Aldana CA, Chow JLM, et al
    Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.
    Oncogene. 2025;44:2831-2849.
    

    >> Share

    
    

    
    Oncol Rep

32. FUJIYOSHI K, Sugihara R, Miyamoto N, Watanabe Y, et al
    Comprehensive genetic profiling using tissue and blood in locally advanced tumors.
    Oncol Rep. 2025;54:134.
    

    >> Share

    
    

    
    PLoS One

33. KHAN AH, Li J, Asghar MN, Iqbal S, et al
    LGD_Net: Capsule network with extreme learning machine for classification of lung diseases using CT scans.
    PLoS One. 2025;20:e0327419.
    

    >> Share

    
    
34. OCHI T, Sakairi Y, Sata Y, Toyoda T, et al
    Indocyanine green intravenous administration can more accurately identify the intersegmental plane than the inflation-deflation method in lung segmentectomy.
    PLoS One. 2025;20:e0328362.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share